Fibromyalgia Treatments · Cymbalta, Elavil, Savella, Lyrica
Fibromyalgia Medication Not Working? How Genetics Affects Your Treatment Options
Fibromyalgia patients often cycle through medications for years. For several of the most commonly used drugs, CYP2D6 and CYP2C19 genetics can explain both poor tolerability and poor effect.
Fibromyalgia is hard to treat, and most patients spend years cycling through medications. The three FDA-approved options (duloxetine/Cymbalta, milnacipran/Savella, and pregabalin/Lyrica) and the commonly used off-label drugs like amitriptyline and tramadol are all affected to varying degrees by pharmacogenetics. If you have burned through several without success, genetics is one of the reasons worth ruling out.
Common reasons fibromyalgia medications fall short
Fibromyalgia medications have modest effect sizes
Even in clinical trials, fibromyalgia medications help about 30 to 50 percent of patients reach a meaningful reduction in pain, and the average pain reduction is around 30 percent. So even when a medication 'works,' many patients still have significant symptoms. Setting realistic expectations with your doctor matters.
Side effects often limit effective dosing
Many fibromyalgia patients are very sensitive to medication side effects, which often keeps them from reaching therapeutic doses. Amitriptyline causes drowsiness and weight gain, duloxetine causes nausea, and pregabalin causes dizziness and brain fog. If side effects force you to stay at a low dose, you may never reach the therapeutic range.
Central sensitization complicates treatment
Fibromyalgia involves altered pain processing in the central nervous system (central sensitization). The pain isn't purely a peripheral signal that traditional painkillers can block. Medications that act on pain processing centrally (SNRIs, tricyclics, anticonvulsants) tend to work better than ones aimed at peripheral pain.
Multimodal treatment is usually necessary
No single medication is enough for most fibromyalgia patients. Exercise, better sleep, stress management, and cognitive behavioral therapy all have evidence behind them for fibromyalgia. Medication alone rarely gives adequate relief.
Tramadol, a common fibromyalgia treatment, is a prodrug that needs CYP2D6 to be activated. Poor metabolizers get essentially no opioid pain relief from it.
How your genetics can play a role
Several fibromyalgia medications have significant pharmacogenetic interactions. Knowing which ones are affected by your genetics can help explain why some treatments fail and guide better choices. There are no CPIC guidelines written specifically for fibromyalgia, but CPIC guidelines cover several drugs used to treat it, including tricyclics[1] and opioids like tramadol.[2]
| Gene | What it affects |
|---|---|
| CYP2D6 | Metabolizes amitriptyline (the most commonly prescribed off-label fibromyalgia medication),[1] nortriptyline, tramadol (often used for fibromyalgia pain),[2] and venlafaxine.[3] About 5 to 10 percent of Caucasians are poor metabolizers. For amitriptyline, over 60 percent of people carry variants in CYP2D6 and/or CYP2C19 that affect dosing. |
| CYP2C19 | Provides a secondary metabolic pathway for amitriptyline[1] and is relevant for SSRIs that may be co-prescribed for fibromyalgia-related depression.[3] Also affects omeprazole, which fibromyalgia patients often take for GI issues from NSAIDs or other medications. |
If you are a CYP2D6 poor metabolizer, amitriptyline accumulates faster than expected.[1] That can cause excessive sedation, cognitive dulling, and weight gain even at the low doses (10 to 25 mg) typically used for fibromyalgia. You might give up on a drug that could have worked at an even lower dose. If you are an ultrarapid metabolizer, standard doses may never build up enough to help. Tramadol, another common fibromyalgia treatment, is a prodrug that needs CYP2D6 to be activated.[2] Poor metabolizers get essentially no opioid pain relief from tramadol, which makes it useless for their fibromyalgia pain.
Want to know what your genetics say about how you'll respond to Amitriptyline?
A Gene2Rx report reads your own DNA to show how it may affect your response to Amitriptyline and your other medications.
Find out todayWhen to consider pharmacogenetic testing
Pharmacogenetic testing is useful for fibromyalgia patients because the condition usually requires trying several medications, and knowing which ones your body can process properly narrows the field a lot. Test if you have tried amitriptyline, duloxetine, or tramadol without success, if you are unusually sensitive to medication side effects, or if you want a better shot at finding an effective treatment sooner. A Gene2Rx report covers CYP2D6 and CYP2C19 across 110 medications for $49, or a psychiatric-focused report covering the most relevant genes for $35.[4]
What you can do next
- Keep a detailed symptom diary tracking pain levels, sleep quality, fatigue, and medication effects. This gives your doctor data to work with.
- Consider pharmacogenetic testing for CYP2D6 and CYP2C19, especially if you have tried amitriptyline or tramadol without success.
- Talk through the full range of fibromyalgia medications with your doctor. Duloxetine, milnacipran, pregabalin, gabapentin, amitriptyline, and nortriptyline all have different mechanisms and genetic dependencies.
- Don't neglect non-medication treatments. Regular aerobic exercise is one of the most consistently effective interventions for fibromyalgia.
- If tramadol doesn't work for pain, don't assume all pain medications will fail. The issue may be CYP2D6 poor metabolism, not pain medication resistance.
Related medications
Related guides
- Migraine Medication Not Working? How Genetics Affects Your Treatment
- 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
- AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data
- Looking for a GeneSight Alternative? Here's the Short Answer
- Looking for a Genomind Alternative? Here's What to Know
- MyHeritage Pharmacogenetics: Use Your MyHeritage DNA for a Drug Response Report
Frequently asked questions
Is pregabalin (Lyrica) affected by pharmacogenetics?
Pregabalin is mostly eliminated by the kidneys without significant liver metabolism, so it isn't meaningfully affected by CYP2D6 or CYP2C19 genetics. If you are a CYP2D6 poor metabolizer who can't tolerate amitriptyline or tramadol, pregabalin may be a better option for your fibromyalgia.
Why does amitriptyline cause so many side effects for some fibromyalgia patients?
Fibromyalgia patients often report heightened sensitivity to medications in general, possibly related to central sensitization. On top of that, CYP2D6 poor metabolizers accumulate higher amitriptyline levels than expected. General medication sensitivity plus genetically elevated drug levels can make standard fibromyalgia doses intolerable.
Should I try duloxetine (Cymbalta) or amitriptyline first?
This depends partly on your symptoms and partly on your genetics. Duloxetine is FDA-approved for fibromyalgia and has fewer anticholinergic side effects. Amitriptyline may be more effective for sleep problems but has more side effects. Pharmacogenetic testing can inform this decision: duloxetine is less affected by CYP2D6 than amitriptyline, which can make it safer for poor metabolizers.
References
- CPIC. CPIC Guideline for Tricyclic Antidepressants and CYP2D6 and CYP2C19 (2016). cpicpgx.org
- CPIC. CPIC Guideline for Opioids (Codeine, Tramadol) and CYP2D6, OPRM1, and COMT (2021). cpicpgx.org
- CPIC. CPIC Guideline for SSRI and SNRI Antidepressants and CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A (2023). cpicpgx.org
- Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.